Publications by authors named "Daniel Giles"

Article Synopsis
  • * The research tested how leptin activates its receptors in the brain, specifically focusing on its impact on serotonergic neurons in the dorsal raphe nucleus (DRN) that communicate with the arcuate (ARC) region.
  • * Results showed that leptin decreases food intake in rats by acting through these serotonergic neurons, highlighting a new pathway that connects leptin and serotonin in regulating eating behavior, which could lead to better treatments for eating disorders.
View Article and Find Full Text PDF

To understand the role of T cells in the pathogenesis of ulcerative colitis (UC), we analyzed colonic T cells isolated from patients with UC and controls. Here we identified colonic CD4 and CD8 T lymphocyte subsets with gene expression profiles resembling stem-like progenitors, previously reported in several mouse models of autoimmune disease. Stem-like T cells were increased in inflamed areas compared to non-inflamed regions from the same patients.

View Article and Find Full Text PDF

Introduction: Inflammation is a common unifying factor in experimental models of non-alcoholic fatty liver disease (NAFLD) progression. Recent evidence suggests that housing temperature-driven alterations in hepatic inflammation correlate with exacerbated hepatic steatosis, development of hepatic fibrosis, and hepatocellular damage in a model of high fat diet-driven NAFLD. However, the congruency of these findings across other, frequently employed, experimental mouse models of NAFLD has not been studied.

View Article and Find Full Text PDF

Colitis is characterized by an exacerbated intestinal immune response, but the genetic and other mechanisms regulating immune activation remain incompletely understood. In order to identify new pathways leading to colitis, we sought to identify genes with increased expression in the colons of patients that also are near loci identified by genome wide association studies (GWAS) associated with IBD risk. One such SNP, rs9557195 was of particular interest because it is within an intron of , known to be important for lymphocyte migration.

View Article and Find Full Text PDF

Purpose: To review the evidence around self-management interventions used to improve mobility post-stroke.

Materials And Methods: An integrative review was carried out. Eight databases were searched from 1992 to July 2021 using keywords based on the PICOS strategy.

View Article and Find Full Text PDF

Emerging evidence suggests a key contribution to non-alcoholic fatty liver disease (NAFLD) pathogenesis by Th17 cells. The pathogenic characteristics and mechanisms of hepatic Th17 cells, however, remain unknown. Here, we uncover and characterize a distinct population of inflammatory hepatic CXCR3Th17 (ihTh17) cells sufficient to exacerbate NAFLD pathogenesis.

View Article and Find Full Text PDF

Inflammatory bowel disease is characterized by an exacerbated intestinal immune response, but the critical mechanisms regulating immune activation remain incompletely understood. We previously reported that the TNF-superfamily molecule TNFSF14 (LIGHT) is required for preventing severe disease in mouse models of colitis. In addition, deletion of lymphotoxin beta receptor (LTβR), which binds LIGHT, also led to aggravated colitis pathogenesis.

View Article and Find Full Text PDF

Innate lymphoid cells (ILCs) are important regulators of the early responses to infection at mucosal barriers, including the intestine. Recently, we have shown that specific ILC3 subsets protect against enteric bacterial pathogens. Here, we describe a mouse model of oral infection by Yersinia enterocolitica (Y.

View Article and Find Full Text PDF

Innate lymphoid cells (ILCs) are a lymphocyte population that is mostly resident at mucosal surfaces. They help to induce an appropriate immune response to the microbiome at homeostasis. In healthy people, the mucosal immune system works symbiotically with organisms that make up the microbiota.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory Bowel Diseases (IBDs) are chronic conditions affecting the gastrointestinal tract, with treatments like biological therapies showing varied effectiveness due to their complexity and immunogenicity.
  • Recent advancements in understanding IBD mechanisms have led to new treatment options, particularly focusing on small molecules (SMs) which are easier to administer and less likely to provoke immune responses.
  • Janus Kinase (JAK) inhibitors and Sphingosine-1-Phosphate Receptor (S1PR) agonists are emerging as promising SM treatments for IBD, targeting specific pathways that contribute to the disease's pathology.
View Article and Find Full Text PDF

Over 1.5 million individuals in the United States are afflicted with inflammatory bowel disease (IBD). While the progression of IBD is multifactorial, chronic, unresolved inflammation certainly plays a key role.

View Article and Find Full Text PDF

Innate lymphoid cells (ILCs) are important regulators of early infection at mucosal barriers. ILCs are divided into three groups based on expression profiles, and are activated by cytokines and neuropeptides. Yet, it remains unknown if ILCs integrate other signals in providing protection.

View Article and Find Full Text PDF
Article Synopsis
  • Nonalcoholic fatty liver disease (NAFLD) encompasses a range of liver issues from mild fat accumulation to serious conditions like cirrhosis and cancer, with inflammation and oxidative stress playing key roles in its progression.
  • Elevated reactive oxygen species (ROS) production, particularly from immune cells, is linked to NAFLD, and the NOX2 enzyme has been identified as a significant contributor to this process, affecting both inflammation and metabolism during obesity.
  • Research showed that eliminating NOX2 in mice reduced ROS levels, lessened liver inflammation and damage, and indicated that targeting NOX2 could be a potential strategy for treating obesity-related NAFLD.
View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD), a metabolic predisposition for development of hepatocellular carcinoma (HCC), represents a disease spectrum ranging from steatosis to steatohepatitis to cirrhosis. Acox1, a rate-limiting enzyme in peroxisomal fatty acid β-oxidation, regulates metabolism, spontaneous hepatic steatosis, and hepatocellular damage over time. However, it is unknown whether Acox1 modulates inflammation relevant to NAFLD pathogenesis or if Acox1-associated metabolic and inflammatory derangements uncover and accelerate potential for NAFLD progression.

View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD), a common prelude to cirrhosis and hepatocellular carcinoma, is the most common chronic liver disease worldwide. Defining the molecular mechanisms underlying the pathogenesis of NAFLD has been hampered by a lack of animal models that closely recapitulate the severe end of the disease spectrum in humans, including bridging hepatic fibrosis. Here we demonstrate that a novel experimental model employing thermoneutral housing, as opposed to standard housing, resulted in lower stress-driven production of corticosterone, augmented mouse proinflammatory immune responses and markedly exacerbated high-fat diet (HFD)-induced NAFLD pathogenesis.

View Article and Find Full Text PDF

Preterm birth (PTB) is a leading worldwide cause of morbidity and mortality in infants. Maternal inflammation induced by microbial infection is a critical predisposing factor for PTB. However, biological processes associated with competency of pathogens, including viruses, to induce PTB or sensitize for secondary bacterial infection-driven PTB are unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Recent research highlights the significant role of obesity and inflammation in driving atherosclerosis, a major global health issue.
  • Standard mouse models struggle to accurately represent human atherosclerosis, but housing mice in their thermoneutral zone while on a high-fat diet may enhance our understanding of disease mechanisms.
  • This study found that ApoE and wild-type mice housed at thermoneutral temperatures developed greater obesity and atherosclerosis compared to those kept at standard temperatures, indicating a potential new model for atherosclerosis research.
View Article and Find Full Text PDF

Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is associated with an enhanced risk for liver and cardiovascular diseases and mortality. NAFLD can progress from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH). However, the mechanisms predisposing to this progression remain undefined.

View Article and Find Full Text PDF

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. While it is well-accepted that inflammation is central to NAFLD pathogenesis, the immune pathway(s) orchestrating disease progression are poorly defined. Notably, IL-17RA signaling, via IL-17A, plays an important role in obesity-driven NAFLD pathogenesis.

View Article and Find Full Text PDF

Obesity is a primary risk factor for the development of non-alcoholic fatty liver disease (NAFLD). NAFLD, the most common chronic liver disease in the world, represents a spectrum of disorders that range from steatosis (NAFL) to steatohepatitis (NASH) to cirrhosis. It is anticipated that NAFLD will soon surpass chronic hepatitis C infection as the leading cause for needing liver transplantation.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammation is a key factor in obesity-related health issues, particularly in the development of nonalcoholic fatty liver disease (NAFLD), which is now the most common chronic liver disease in developed countries.
  • Research shows that mice lacking IL-17RA experienced more weight gain and fat accumulation when on a high-fat diet but had less liver damage compared to normal mice, suggesting a complex relationship between obesity and liver health.
  • The study concludes that the IL-17 signaling pathway plays a crucial role in the worsening of NAFLD and could be a promising target for new treatments.
View Article and Find Full Text PDF

Alterations in the gut microbiota have been proposed to modify the development and maintenance of obesity and its sequelae. Definition of underlying mechanisms has lagged, although the ability of commensal gut microbes to drive pathways involved in inflammation and metabolism has generated compelling, testable hypotheses. We studied C57BL/6 mice from two vendors that differ in their obesogenic response and in their colonization by specific members of the gut microbiota having well-described roles in regulating gut immune responses.

View Article and Find Full Text PDF